PRIMARY VECTOR
SYSTEMIC OPTIMIZATION
CLINICAL EFFICACY
DATA PENDING CLINICAL REVIEW
NCBI VERIFICATION
AWAITING PUBMED INDEX
WHAT IS IT?
An off-label, micro-dosed version of an FDA-approved opioid antagonist.
WHAT DOES IT DO?
Triggers a rebound effect causing a 300% increase in endorphins, crippling autoimmune inflammation.
HOW DO I USE IT?
Taken via prescription oral compounding (1.5mg to 4.5mg) strictly at night right before bed.
DEPLOYED BY OPERATORSHEALTHTRENDS SCORE™
11Dave Asprey
89.0